title: Attitudes of men in an Australian male tolerance study towards microbicide use.
abstract: BACKGROUND
  Vaginal microbicides are in development to provide new options for the prevention of sexually transmissible infections. Although promoted as a female-initiated product, men may influence the decision to use a microbicide and the way that it is used, so it is important to explore their views.
  
  
  METHODS
  Men (n = 36) enrolled in a 7-day, phase 1 clinical safety trial of SPL7013 Gel were interviewed pre- and post-use of the gel. The trial did not include use of the gel during sex. Interviews were digitally-recorded and transcribed verbatim, and analysed using a framework approach.
  
  
  RESULTS
  The men (mean age 37 years) were interested in the idea of vaginal microbicides, had little knowledge about them, and varied beliefs about how they work. They tended to assess microbicide use in relation to condoms and lubricants. Many would want a microbicide to be as effective as condoms. Participants did not anticipate difficulties discussing use with their partners. Many thought that a microbicide would be less intrusive than condoms; some anticipated that the lubricating properties might enhance sexual pleasure. Some anticipated using a microbicide with a condom or with a lubricant, and a few raised questions about the timing of use and use during different types of sexual activity.
  
  
  CONCLUSIONS
  No major barriers to microbicide use were found in this sample of Australian men, who anticipated being willing to use them if they are shown to be safe and effective. Our findings should help to inform the design of further studies as well as future information materials and anticipatory guidance.
authors.affiliation: Centre for International Health, Macfarlane Burnet Institute for Medical Research and Public Health, 23?87 Commercial Road, Melbourne, Vic. 3004, Australia. holmes@burnet.edu.au
authors.forename: Wendy R
authors.initials: WR
authors.lastname: Holmes
authors.forename: Lisa
authors.initials: L
authors.lastname: Maher
authors.forename: Susan L
authors.initials: SL
authors.lastname: Rosenthal
mesh_terms: D000282:Administration, Intravaginal; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001315:Australia; D050091:Dendrimers; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000523:psychology*; D011107:Polylysine / Q000009:adverse effects / Q000627:therapeutic use*; D021841:Safe Sex / Q000523:psychology; D015231:Sexually Transmitted Diseases, Bacterial / Q000517:prevention & control*; D013089:Spermatocidal Agents / Q000627:therapeutic use; D011795:Surveys and Questionnaires
chemical_list: D000890:Anti-Infective Agents; D050091:Dendrimers; D013089:Spermatocidal Agents; D011107:Polylysine; C480351:astodrimer
references.citation: J Adolesc Health. 2006 Dec;39(6):893-9
references.pmid: 17116521
references.citation: Women Health. 1995;23(2):31-46
references.pmid: 8585224
references.citation: Lancet. 2007 Mar 3;369(9563):787-797
references.pmid: 17336656
references.citation: Aust N Z J Public Health. 2003;27(2):146-54
references.pmid: 14696705
references.citation: Reprod Health Matters. 2000 May;8(15):132-41
references.pmid: 11424261
references.citation: Aust N Z J Public Health. 2003;27(2):180-90
references.pmid: 14696709
references.citation: Sex Health. 2005;2(2):109-15
references.pmid: 16335748
references.citation: Int J STD AIDS. 1999 Apr;10(4):258-62
references.pmid: 12035780
references.citation: Adv Data. 2005 Sep 15;(362):1-55
references.pmid: 16250464
references.citation: Soc Sci Med. 2006 Oct;63(8):1998-2009
references.pmid: 16814912
references.citation: Int J STD AIDS. 1998 Jun;9(6):330-5
references.pmid: 9671246
references.citation: Lancet. 2007 Jul 7;370(9581):10-1
references.pmid: 17617254
references.citation: Fam Plann Perspect. 2000 Jul-Aug;32(4):184-8
references.pmid: 10942354
references.citation: J Womens Health (Larchmt). 2005 Jun;14(5):424-33
references.pmid: 15989415
references.citation: AIDS Care. 2004 Apr;16(3):315-22
references.pmid: 15203425
references.citation: N Engl J Med. 2006 Jun 22;354(25):2645-54
references.pmid: 16790697
references.citation: Sex Transm Dis. 2007 Nov;34(11):900-7
references.pmid: 17538513
references.citation: AIDS. 2003 May 23;17(8):1227-37
references.pmid: 12819525
references.citation: Am J Public Health. 1994 Dec;84(12):1960-4
references.pmid: 7998637
references.citation: J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):375-80
references.pmid: 19214122
references.citation: Lancet. 2007 Jul 7;370(9581):17-8
references.pmid: 17632853
references.citation: Sex Health. 2007 Mar;4(1):51-6
references.pmid: 17382039
references.citation: Bull World Health Organ. 2004 Jun;82(6):454-61
references.pmid: 15356939
references.citation: AIDS. 1995 Dec;9(12):1357-65
references.pmid: 8605056
references.citation: AIDS Patient Care STDS. 1999 Dec;13(12):717-30
references.pmid: 10743535
references.citation: BMJ. 2006 Mar 11;332(7541):605-7
references.pmid: 16528088
references.citation: Sex Transm Infect. 2004 Jun;80(3):159-66
references.pmid: 15169995
references.citation: Am J Public Health. 2006 Jan;96(1):79-83
references.pmid: 16317214
references.citation: Am J Public Health. 2004 Jul;94(7):1159-64
references.pmid: 15226137
references.citation: Ann Intern Med. 2005 Nov 15;143(10):707-13
references.pmid: 16287791
references.citation: Infect Dis Clin North Am. 2005 Jun;19(2):281-96
references.pmid: 15963872
references.citation: AIDS Behav. 2005 Mar;9(1):121-31
references.pmid: 15812619
references.citation: AIDS Care. 2007 Sep;19(8):1026-31
references.pmid: 17852000
references.citation: J Womens Health (Larchmt). 2003 Sep;12(7):655-66
references.pmid: 14583106